Condition

Squamous Cell Carcinoma of the Cervix

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions7

Lead sponsors shown4

Clinical trials

4 shown

A Study of IDP-001 in Advanced or Metastatic Solid TumorsNCT07602842 · 2026-07-08

RECRUITING

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasNCT03894618 · 2019-03-26

COMPLETED

PEN-866 in Patients With Advanced Solid MalignanciesNCT03221400 · 2017-08-29

UNKNOWN

A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerNCT02042885 · 2014-01-01

TERMINATED

Common interventions

fluorouracilDRUG1Folinic acidDRUG1IDP-001DRUG1NiraparibDRUG1OPB-111001DRUG1PEN-866 SodiumDRUG1SL-279252DRUG1

Leading sponsors

InduPro, Inc.1Otsuka Novel Products GmbH1Shattuck Labs, Inc.1Tarveda Therapeutics1

Trial status mix

COMPLETED1

RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

PHASE14

PHASE23

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.